title: Interview: Interview with Professor Malcolm Rowland.
abstract: Malcolm Rowland is Professor Emeritus and former Dean of the School of Pharmacy and Pharmaceutical Sciences and a member and former director (1996-2000), of the Centre for Applied Pharmacokinetic Research, University of Manchester. He holds the positions of Adjunct Professor, School of Pharmacy, University of California, San Francisco; Member, Governing Board, EU Network of Excellence in Biosimulation; Founder member of NDA Partners; academic advisor to a Pharmaceutical initiative in prediction of human pharmacokinetics and Scientific Advisor to the EU Microdose AMS Partnership Program. He was President of the EU Federation for Pharmaceutical Sciences (1996-2000); Vice-President of the International Pharmaceutical Federation (2001-2009) and a Board Member of the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs, 2004-2008). He received his degree in Pharmacy and PhD at the University of London and was on faculty (School of Pharmacy, University of California San Francisco [1967-1975]) before taking up a professorship at Manchester. His main research interest is physiologically based pharmacokinetics and its application to drug discovery, development and use. He is author of over 300 scientific articles and co-author, with TN Tozer, of the textbooks Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications and Introduction to Pharmacokinetics and Pharmacodynamics. He was editor of the Journal of Pharmacokinetics and Pharmacodynamics (formerly Journal of Pharmacokinetics and Biopharmaceutics, 1973-2007) and, since 1977, has organized regular residential workshops in pharmacokinetics.
authors.forename: Malcolm
authors.initials: M
authors.lastname: Rowland
mesh_terms: D000042:Absorption; D000818:Animals; D017321:Clinical Trials, Phase I as Topic; D017277:Drug Approval; D055808:Drug Discovery / Q000379:methods*; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D016014:Linear Models; D046911:Macromolecular Substances / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics; D017711:Nonlinear Dynamics; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010599:Pharmacokinetics; D015203:Reproducibility of Results; D012449:Safety; D012957:Societies, Pharmaceutical
chemical_list: D046911:Macromolecular Substances; D004364:Pharmaceutical Preparations